ugichem is a biotech company that develops antisense drugs for therapeutic applications.
ugichem is an innovative biotech company based on unique chemistry and focused on the development of novel antisense drugs. Their mission is to turn antisense into therapeutics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 17, 2007 | Series B | $1.08M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BioScience Ventures Group | — | Series B |